{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Mrs. Clinton appears to be more willing to confront insurers and drug makers over high prices, going beyond such measures in the Affordable Care Act.", "headline": {"main": "Hillary Clinton\u2019s Health Care Proposals, Focused on Cost, Go Well Beyond Obama\u2019s", "print_headline": "Clinton&#8217;s Health Care Proposals, Focused on Cost, Go Well Beyond Obama&#8217;s"}, "abstract": "Hillary Rodham Clinton offers health care proposals that she says venture far beyond those of Pres Obama and Affordable Care Act, including capping some patient costs and stopping what she calls 'unconscionable profiteering' by insurance companies and drug firms; comments cause consternation among Obama administration officials, who say they were not consulted by the Clinton campaign. ", "print_page": "18", "word_count": "1305", "_id": "56140746798810321b0fab99", "snippet": "Mrs. Clinton appears to be more willing to confront insurers and drug makers over high prices, going beyond such measures in the Affordable Care Act.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/10/07/us/politics/hillary-clintons-proposed-changes-to-health-law-zero-in-on-affordability.html", "multimedia": [{"subtype": "wide", "url": "images/2015/10/07/us/07health-web/07health-web-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/10/07/us/07health-web/07health-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/10/07/us/07health-web/07health-web-articleLarge.jpg", "height": 399, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/10/07/us/07health-web/07health-web-articleLarge.jpg", "xlargeheight": "399"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/10/07/us/07health-web/07health-web-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/10/07/us/07health-web/07health-web-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Politics", "keywords": [{"value": "Health Insurance and Managed Care", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Patient Protection and Affordable Care Act (2010)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Presidential Election of 2016", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Clinton, Hillary Rodham", "is_major": "Y", "rank": "4", "name": "persons"}, {"value": "Obama, Barack", "is_major": "N", "rank": "5", "name": "persons"}, {"value": "Democratic Party", "is_major": "N", "rank": "6", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2015-10-07T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "California's governor has signed a bill that will give the terminally ill in the nation's most populous state the right to end their lives with drugs prescribed by a doctor.", "headline": {"main": "A Look at Efforts to Legalize Physician-Assisted Deaths", "print_headline": "A Look at Efforts to Legalize Physician-Assisted Deaths"}, "abstract": null, "print_page": null, "word_count": "740", "_id": "56145b24798810321b0facec", "snippet": "California's governor has signed a bill that will give the terminally ill in the nation's most populous state the right to end their lives with drugs prescribed by a doctor.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/10/06/us/ap-us-right-to-die-california-qa.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-10-06T18:34:46Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "The Pacific trade deal agreed on Monday, which grants biotechnology drug producers less protection than offered by the United States, could put more downward pressures on the costly drugs' pricing in the industry's most lucrative market.", "headline": {"main": "Pacific Trade Deal Adds to U.S. Price Quandary for Biotech Drugs", "print_headline": "Pacific Trade Deal Adds to U.S. Price Quandary for Biotech Drugs"}, "abstract": null, "print_page": null, "word_count": "893", "_id": "56138c51798810058bee0d7f", "snippet": "The Pacific trade deal agreed on Monday, which grants biotechnology drug producers less protection than offered by the United States, could put more downward pressures on the costly drugs' pricing in the industry's most lucrative market.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2015/10/06/business/06reuters-trade-tpp-biotech.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2015-10-06T04:51:26Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "The Pacific trade deal agreed on Monday, which grants biotechnology drug producers less protection than offered by the United States, could put more downward pressures on the costly drugs' pricing in the industry's most lucrative market.", "headline": {"main": "Pacific Trade Deal Adds to U.S. Price Quandary for Biotech Drugs", "print_headline": "Pacific Trade Deal Adds to U.S. Price Quandary for Biotech Drugs"}, "abstract": null, "print_page": null, "word_count": "893", "_id": "5612e387798810058bee0c36", "snippet": "The Pacific trade deal agreed on Monday, which grants biotechnology drug producers less protection than offered by the United States, could put more downward pressures on the costly drugs' pricing in the industry's most lucrative market.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2015/10/05/business/05reuters-trade-tpp-biotech.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2015-10-05T16:53:19Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "In a rare personal message, California's 77-year-old governor provided insight into his deliberations before deciding to sign a bill allowing terminally ill Californians to legally take their own lives, reflecting on religion and self-determination as he weighed an emotionally fraught choice.", "headline": {"main": "Gov. Brown Signs California Right-To-Die Measure", "print_headline": "Gov. Brown Signs California Right-To-Die Measure"}, "abstract": null, "print_page": null, "word_count": "610", "_id": "5612d3a5798810058bee0bfa", "snippet": "In a rare personal message, California's 77-year-old governor provided insight into his deliberations before deciding to sign a bill allowing terminally ill Californians to legally take their own lives, reflecting on religion and self-determination...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/10/05/us/ap-us-xgr-right-to-die-california.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-10-05T15:43:52Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "The United States and 11 other Pacific Rim countries reached a contentious trade pact that cuts trade barriers, sets labor and environmental standards and protects the intellectual property of multinational corporations. Now each country must sell the deal to skeptical lawmakers.", "headline": {"main": "United States, 11 Pacific Rim Countries Reach Trade Deal", "print_headline": "United States, 11 Pacific Rim Countries Reach Trade Deal"}, "abstract": null, "print_page": null, "word_count": "910", "_id": "56127c3c798810659687978a", "snippet": "The United States and 11 other Pacific Rim countries reached a contentious trade pact that cuts trade barriers, sets labor and environmental standards and protects the intellectual property of multinational corporations. Now each country must sell...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/10/05/us/ap-us-trade-pacific-agreement.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-10-05T09:31:05Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Latest developments in the announcement of the Nobel Prize in Medicine (all times local):", "headline": {"main": "The Latest: Discovery on Golf Course Inspired Nobel Winner", "print_headline": "The Latest: Discovery on Golf Course Inspired Nobel Winner"}, "abstract": null, "print_page": null, "word_count": "821", "_id": "56124c787988106596879708", "snippet": "Latest developments in the announcement of the Nobel Prize in Medicine (all times local):", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/10/05/world/europe/ap-eu-nobel-medicine-the-latest.html", "multimedia": [], "subsection_name": "Europe", "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-10-05T06:08:43Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "A pharmaceutical company buys old drugs and increases the price multifold, a profitable business model that is drawing anger and making the traditional drug industry nervous.", "headline": {"main": "Valeant\u2019s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers", "print_headline": "A Drug Company&#8217;s Price Tactics Pinch Insurers and Consumers"}, "abstract": "Valeant Pharmaceuticals International has outperformed its rivals in industry due in large part to executive J Michael Pearson's aggressive practice of buying up existing drugs and then raising prices on them significantly, but tactic has drawn ire of consumers and attention of regulators; focus of regulators has many in industry worried, as many companies employ similar tactic, though not to extreme Valeant does.", "print_page": "1", "word_count": "1668", "_id": "5610f8be79881051da04d0ef", "snippet": "A pharmaceutical company buys old drugs and increases the price multifold, a profitable business model that is drawing anger and making the traditional drug industry nervous.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/10/05/business/valeants-drug-price-strategy-enriches-it-but-infuriates-patients-and-lawmakers.html", "multimedia": [{"subtype": "wide", "url": "images/2015/10/02/business/02drugprices-web1/02drugprices-web1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/10/02/business/02drugprices-web1/02drugprices-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/10/02/business/02drugprices-web1/02drugprices-web1-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/10/02/business/02drugprices-web1/02drugprices-web1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/10/02/business/02drugprices-web1/02drugprices-web1-thumbStandard-v2.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/10/02/business/02drugprices-web1/02drugprices-web1-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Pearson, John Michael (1959- )", "is_major": "Y", "rank": "3", "name": "persons"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Sabrina", "lastname": "TAVERNISE"}], "original": "By ANDREW POLLACK and SABRINA TAVERNISE"}, "document_type": "article", "pub_date": "2015-10-05T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.", "headline": {"main": "FDA Expands Merck Drug's Approval to Treat Lung Cancer", "print_headline": "FDA Expands Merck Drug's Approval to Treat Lung Cancer"}, "abstract": null, "print_page": null, "word_count": "395", "_id": "560ed02b7988102790c675db", "snippet": "Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/10/02/business/ap-us-merck-cancer-drug.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-10-02T14:39:35Z", "section_name": "Business Day"}], "meta": {"hits": 9, "offset": 0, "time": 75}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}